Phil Bonomi
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
-
- Cancer survivorship and care
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 1
- Oncology 2
- Cancer survivorship and care 1
- Lung Cancer Research Studies 1
- Co-authors
- David F Cella (2 shared papers)Diane L. Fairclough (2 shared papers)John J. Haluschak (1 shared paper)Hak Choy (1 shared paper)Charles Scott (1 shared paper)Patrick M. Travis (1 shared paper)Chandra Prakash Belani (1 shared paper)Walter John Curran (1 shared paper)
- Journals
- Seminars in Oncology (1 paper)Statistics in Medicine (1 paper)Journal of Clinical Oncology (1 paper)Clinical Lung Cancer (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Phil Bonomi
7 papers receiving 793 citations
Peers
Comparison fields: 5 of 41
- Pulmonary and Respiratory Medicine 386
- Oncology 115
- Statistics and Probability 32
- Radiation 15
- Economics and Econometrics 28
Countries citing papers authored by Phil Bonomi
This map shows the geographic impact of Phil Bonomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Bonomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Bonomi more than expected).
Fields of papers citing papers by Phil Bonomi
This network shows the impact of papers produced by Phil Bonomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Bonomi. The network helps show where Phil Bonomi may publish in the future.
Co-authors
The 25 scholars most cited alongside Phil Bonomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 352 | |
| 2 | 2002 | 351 | |
| 3 | 1998 | 110 | |
| 4 | 2020 | 11 | |
| 5 | 2001 | 10 | |
| 6 | 2020 | 2 | |
| 7 | Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma. | 1988 | 1 |
About Phil Bonomi
Phil Bonomi is a scholar working on Toxicology, Oncology, Statistics and Probability, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 7 papers that have together received 837 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (1 paper), Cancer survivorship and care (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Lung Cancer Research Studies (1 paper), Ethics in Clinical Research (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper) and Statistical Methods and Bayesian Inference (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (386 citations), Oncology (115 citations), Statistics and Probability (32 citations), Radiation (15 citations) and Economics and Econometrics (28 citations). Phil Bonomi has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include David F Cella, Diane L. Fairclough, John J. Haluschak, Hak Choy, Charles Scott, Patrick M. Travis, Chandra Prakash Belani, Walter John Curran, Cheryl Silberman and Anne Heyes. Their work appears in journals such as Seminars in Oncology, Statistics in Medicine, Journal of Clinical Oncology, Clinical Lung Cancer and Therapeutic Innovation & Regulatory Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.